Der psychoaktive Spezialextrakt WS 1490 aus dem Wurzelstock von Piper methysticum (Kava-Kava) – ein Report

1994 ◽  
Vol 1 (5) ◽  
pp. 208-215 ◽  
Author(s):  
M. Habs ◽  
E. Honold
Keyword(s):  
2003 ◽  
Vol 64 (2) ◽  
pp. 216-228 ◽  
Author(s):  
Robert Bernhard Brauer ◽  
Manfred Stangl ◽  
Jorg Rudiger Siewert ◽  
Rudolf Pfab ◽  
Karen Becker

2009 ◽  
Vol 28 (6_suppl) ◽  
pp. 175S-188S ◽  
Author(s):  
Valerie Robinson ◽  
Wilma F. Bergfeld ◽  
Donald V. Belsito ◽  
Curtis D. Klaassen ◽  
James G. Marks ◽  
...  

Piper methysticum leaf/root/stem extract is the cosmetic ingredient name for a material derived from the leaves, roots, and stems of the Piper methysticum G. Forster plant, commonly known as kava kava. This and other kava-derived ingredients are used as skin-conditioning agents at concentrations from 0.0001% to 0.1%. The Food and Drug Administration issued a consumer advisory in 2002 expressing concern about liver damage in individuals who have ingested kava products. The available oral toxicity data support the concern about liver damage on ingestion but do not resolve the question, for example, whether these ingredients would be substantially absorbed through the skin. Other data needs are described, including toxicology data for yangonin, methysticin, and kavain, which may be present in kava-derived ingredients. Accordingly, the available data are insufficient to support the safety of these ingredients in cosmetics.


Author(s):  
Elaine Cristina Gurgel Andrade Pedrosa ◽  
Ana Paula Carvalho Bezerra ◽  
Ianara Mendonça da Costa ◽  
Francisco Irochima Pinheiro ◽  
Fausto Pierdoná Guzen

2008 ◽  
Vol 5 (1) ◽  
Author(s):  
Seilin Cardoso Justo ◽  
Chana Medeiros Silva ◽  
Chana Medeiros Silva
Keyword(s):  

Author(s):  
Mark Merlin ◽  
William Raynor

The kava plant, Piper methysticum Forst. f., is an attractive shrub in the pepper family, Piperaceae (figure 12.1). Known by various names in tropical Pacific, such as yagona, kava, kava kava, ’awa, seka, and sakau, it is propagated vegetatively, as are most of the traditional crops in the region. Kava has been used for many centuries to produce psychoactive preparations. Its active principles, several lipidlike substances known as kavalactones, are concentrated in the rootstock and roots. These psychoactive chemicals are ingested traditionally by Pacific islanders as cold-water infusions of chewed, ground, pounded, or otherwise macerated kava stumps and roots. Mind-altering kava preparations are, or once were, imbibed in a wide range of Pacific Ocean societies. These include peoples living in some lowland areas on the large Melanesian island of New Guinea in the western Pacific to very isolated islands such as those in Polynesian Hawai’i, 7,000 kilometers to the northeast (figure 12.2). Beyond this widespread local use in the tropical Pacific, utilization of kava in parts of Europe as a plant source for medicinal preparations has a relatively lengthy history. In Europe it has been used as a sedative, tranquilizer, muscle relaxant, relief from menopausal symptoms, and treatment for urinary tract and bladder ailments (Lebot et al. 1999). Over the past decade, there has been rapidly increasing interest in kava well beyond the areas of traditional use among Pacific Islanders (figure 12.3). This includes a huge surge in the use of kava products in Europe, North America, Australia, and elsewhere. Within the past 3 to 5 years there has been widespread recognition of its potential to emerge as a mainstream herbal product. Modern cultivation and use of kava in the Pacific has significantly expanded in some traditional use areas such as Vanuatu, Fiji, Tonga, Samoa, and Pohnpei. There are also significant signs of rejuvenated interest in kava cultivation in some traditional areas of use where it had been abandoned because of depopulation, political prohibition, or zealous missionary denunciation. Increasing use and cultivation of kava on these Pacific islands has been stimulated by local consumption rates and rising demand for commercial export.


1998 ◽  
Vol 31 (05) ◽  
pp. 187-192 ◽  
Author(s):  
R. Uebelhack ◽  
L Franke ◽  
H.-J. Schewe

2007 ◽  
Vol 83 (1) ◽  
pp. 61-69 ◽  
Author(s):  
B J Gurley ◽  
A Swain ◽  
M A Hubbard ◽  
F Hartsfield ◽  
J Thaden ◽  
...  

2021 ◽  
Vol 7 (4) ◽  
pp. 959-973
Author(s):  
Manuela Conceição da Silva ◽  
Natalia Batista de Souza ◽  
Thifani dos Santos Rocha ◽  
Juliana Azevedo da Paixão ◽  
Ana Maura Carvalho Moura de Alcantara

As medidas de controle recomendadas no contexto da pandemia do COVID-19 tem afetado a população em muitos calibres das condições de vida e de saúde e, entre elas, de forma significativa o componente de saúde mental como a ansiedade e a   depressão. Objetivo: Revisar, através da literatura científica, a eficácia, interações farmacológicas e benefícios do uso dos fitoterápicos kava-kava (Piper methysticum L.) e maracujá (Passiflora incarnata L.) como alternativas terapêuticas para o tratamento do Transtorno de Ansiedade Generalizada (TAG), agravados em tempos de pandemia. Métodos: Trata-se de uma revisão bibliográfica sistemática qualitativa, na qual utilizou-se os sites eletrônicos SciELO, PubMed, Google acadêmico, ANVISA e OMS para a busca de dados. Resultados: Observou-se que os principais benefícios da utilização de fitoterápicos diz respeito ao custo reduzido, à facilidade de acesso e ao baixo índice de efeitos colaterais e reações adversas. Encontrou-se um número considerável de informações que demonstraram a utilização e a procura de fitoterápicos à base de P. Incarnata para tratar as psicopatologias como o TAG, durante o isolamento social e a quarentena. Não foram encontrados números significativos de estudos capazes de comprovar a utilização da P. Methysticum durante a pandemia da COVID-19. Considerações finais: Sugere-se que as espécies P. Incarnata e P. Methysticumão eficazes para o tratamento do TAG por possuir alto valor medicinal com propriedades farmacológicas ansiolíticas, anticonvulsivantes e sedativas.


2008 ◽  
Author(s):  
◽  
Natalie Bruner ◽  

Kava-kava is a widely available and used herbal medicine that is not regulated in many countries, including the United States. There are many questions concerning kava-kava's stimulus properties, potential for therapeutic use, and potential for abuse. Although there is evidence that kava may possess some anxiolytic properties, the supplement's mechanism of action and the extent to which it may serve as an alternative to pharmaceutical anxiolytics are unknown. To date, there is no research examining whether kava shares discriminative-stimulus properties with a standard pharmaceutical anxiolytic such as chlordiazepoxide (CDP). The current study compared different doses of kava in two groups of rats trained to discriminate either a high or low training dose of CDP (i.p.). In order to assess time-course effects of kava (p.o.), two tests were conducted per session at 60 (Test One) and 90 (Test Two) min following administration of kava, CDP, or d-amphetamine. Dose-dependent substitution of CDP was found in both training groups. d-Amphetamine did not substitute for either group at Test One, but marginal substitution was found in both groups at the lower doses of d-amphetamine during Test Two. Kava (560 mg/kg) occasioned responding indicative of partial substitution in both groups during Test One and only the low-dose group during Test Two. Several procedural variables that may have influenced the present results are discussed.


Sign in / Sign up

Export Citation Format

Share Document